The Advanced Medical Technology Assn. (AdvaMed) and the European Medical Technology Industry Assn. (Eucomed) issued a statement on ethical interactions between medical device companies and healthcare professionals.
The statement addresses the industry’s attempt to have consistent transparency and ethical standards across international borders. AdvaMed and Eucomed each have separate ethics codes, but share principles on clinical legitimacy, transparency, independence and the propriety of relationships between companies and healthcare providers.
Under the new pact, the councils committed to working together to “promote ethical interactions among companies and HCPs by encouraging companies to adopt compliance programs and policies consistent with the AdvaMed and/or Eucomed Codes,” according to a press release.
The statement, signed by Stephen J. Ubl and John Wilkinson, chief executives of AdvaMed and Eucomed, respectively, was also signed by Christine Tarrajat, director-general of the European Diagnostic Manufacturers Assn.
